(Q38232407)

31 August 2017

Interstitial photodynamic therapy for prostate cancer: a developing modality (English)

1 reference

31 August 2017

1 reference

Neil E Martin

1

1 reference

PubMed ID

25048183

31 August 2017

Stephen M Hahn

series ordinal

2

1 reference

31 August 2017

1 September 2004

1 reference

Photodiagnosis and Photodynamic Therapy

31 August 2017

1 reference

31 August 2017

1

1 reference

31 August 2017

2

1 reference

31 August 2017

123-136

1 reference

Hematoporphyrin Derivative: A Possible Aid in the Diagnosis and Therapy of Carcinoma of the Bladder

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy for early stage squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy: a new approach to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Results of radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Rising PSA after a radical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Salvage brachytherapy for localized prostate cancer after radiotherapy failure

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy in the treatment of cancer: current state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photoinactivation of Chinese hamster cells by hematoporphyrin derivative and red light

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

1 reference

7 January 2021

Interstitial laser photocoagulation and interstitial photodynamic therapy of normal lung parenchyma in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Optical properties of experimental prostate tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodosimetry of interstitial light delivery to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Interstitial applications of laser irradiation in hematoporphyrin derivative photosensitized dunning R3327 prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Optical dosimetry for interstitial photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Laser dosimetry studies in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

An interstitial light assembly for photodynamic therapy in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

In vivo light transmission spectra in EMT6/Ed murine tumors and Dunning R3327 rat prostate tumors during photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Changes in In Vivo Optical Properties and Light Distributions in Normal Canine Prostate during Photodynamic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Light dosimetry in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

In situ light dosimetry during whole bladder wall photodynamic therapy: clinical results and experimental verification

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Hypoxia in human prostate carcinoma: an Eppendorf PO2 study.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

The uptake of porphyrin and zinc-metalloporphyrin by the primate prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy of prostate cancer: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Transperineal photodynamic ablation of the canine prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Interstitial photodynamic therapy in the canine prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy for colorectal cancer: a quantitative pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Photodynamic therapy of localised prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Prostatic carcinoma: staging with MR imaging at 1.5 T

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Clinical stage B prostate carcinoma: staging with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1572-1000%2804%2900037-7

7 January 2021

10.1016/S1572-1000(04)00037-7

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25048183